Catamount Wealth Management »

Supernus Pharmaceuticals shares owned by Catamount Wealth Management

Quarter-by-quarter ownership of Supernus Pharmaceuticals (SUPN) shares owned by Catamount Wealth Management from 13F filings

Historical chart of Catamount Wealth Management investment in Supernus Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Supernus Pharmaceuticals held by Catamount Wealth Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Supernus Pharmaceuticals by Catamount Wealth Management

Quarter filed Position value Share count Share price at filing
2019-03-31 $5.0k 150 33.33
2018-12-31 $6.0k 150 40.00
2018-09-30 $8.0k 150 53.33
2018-06-30 $7.0k 150 46.67
2018-03-31 $7.0k 150 46.67
2017-12-31 $6.0k 150 40.00